Anzeige
Mehr »
Montag, 11.08.2025 - Börsentäglich über 12.000 News
Desert Gold: Zahlen untermauern das Potential
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Berlin
11.08.25 | 08:01
8,370 Euro
-0,24 % -0,020
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
8,4158,42019:33
8,4158,42019:33

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.07.Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)2
18.07.BioGaia AB: Interim Report January - June 2025110SECOND QUARTER 2025 Net sales amounted to SEK 404.7 million (384.1), an increase of SEK 20.6 million, or an increase of 5% (excluding foreign exchange effects an increase of 13.2%). Net sales in the...
► Artikel lesen
BIOGAIA Aktie jetzt für 0€ handeln
16.07.BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation128As interest in biotics1 and their wide range of health applications continues to grow, BioGaia is proud to announce the launch of a subsidiary company, BioGaia New Sciences AB, dedicated to exploring...
► Artikel lesen
09.07.BioGaia AB's Nomination Committee for the 2026 Annual General Meeting1
08.07.Invitation to media and analyst briefing for BioGaia Q2 2025 report3
30.05.Change in the number of votes in BioGaia AB (publ)1
16.05.BioGaia ranked among TIME's 500 best global companies in sustainable growth11
08.05.Dividendenbekanntmachungen (08.05.2025)11.761 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1052 EUR  AG BARR PLC  GB00B6XZKY75  0,1376 GBP  0,1617 EUR  ALANTRA PARTNERS SA  ES0126501131 - 0...
► Artikel lesen
07.05.Annual General Meeting of BioGaia3
07.05.BioGaia AB establishes direct sales in the Netherlands1
07.05.BioGaia AB: Interim Management Statement January - March 2025230FIRST QUARTER 2025 Net sales amounted to SEK 366.3 million (369.8), a decrease of SEK 3.5 million, or a decrease of 1% (excluding foreign exchange effects a decrease of 3.6%). Net sales in the Pediatrics...
► Artikel lesen
23.04.Invitation to media and analyst briefing for BioGaia Q1 2025 report3
02.04.Notice to attend the Annual General Meeting of BioGaia AB (publ)3
26.03.BioGaia Annual and Sustainability Report 2024 published1
20.03.BioGaia AB: Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder268BioGaia AB (NASDAQ: BIOG) announces that Annwall & Rothschild Investments AB (owned by Jan Annwall and BioGaia's Chairman Peter Rothschild), another member of the Rothschild family and David Dangoor...
► Artikel lesen
12.02.BioGaia AB: Year-end report January - December 2024189FOURTH QUARTER 2024 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified). Net sales amounted to SEK 364.8 million (297.8), an increase of SEK 67.1 million...
► Artikel lesen
04.02.BioGaia AB: BioGaia's results for the fourth quarter to exceed market expectations231(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2024, BioGaia reports growth across all regions with stronger performance in Americas and stronger...
► Artikel lesen
22.10.24BioGaia AB: Interim Management Statement January - September 2024333THIRD QUARTER 2024 (For balance sheet items, figures in parentheses refer to year-end 2023 figures. For income statement and cash flow items, they refer to the same period last year). Net sales amounted...
► Artikel lesen
17.10.24BioGaia AB: BioGaia's preliminary results for the third quarter did not reach market expectations249(Figures in the brackets refer to the same period the previous year) During the third quarter of 2024, BioGaia will record a non-cash impairment of SEK 51.2 million, relating to the acquisition of...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1